{"nctId":"NCT00243243","briefTitle":"Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn","startDateStruct":{"date":"2006-01"},"conditions":["Burns"],"count":20,"armGroups":[{"label":"rFVIIa","type":"EXPERIMENTAL","interventionNames":["Drug: Recombinant Factor VIIa"]},{"label":"Control","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Recombinant Factor VIIa","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female\n* Burn wounds\n* 18-65 years of age\n* Scheduled excision of burn wound of at least 20 percent TBSA\n\nExclusion Criteria:\n\n* Age greater than 65 years\n* History of blood coagulation disorders\n* Taking anti-coagulation medication\n* Contraindication for heparin therapy\n* Pregnant or nursing females\n* Unstable angina\n* MI within the last 6 months\n* Recent of diagnosis of DVT, stroke within the last 6 months\n* Renal failure requiring dialysis or creatinine clearance less than 25 ml/min\n* Religious prohibition to blood transfusion\n* Have received rFVIIa during current hospitalization\n* Previous enrollment in this study","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Total Number of Blood Components Transfused During and up to 24 Hours Post Operatively","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"68.9","spread":null},{"groupId":"OG001","value":"87.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"4.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.02","spread":null},{"groupId":"OG001","value":"6.45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.02","spread":null},{"groupId":"OG001","value":"33.44","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":7,"n":10},"commonTop":["Infection","Hypotension","Pleural Effusion","Decreased Oxygen Saturation","Liver Injury"]}}}